Pesquisas alternativas:
tumor re » tumor role (Expandir a Pesquisa), tumor rna (Expandir a Pesquisa)
tumor 1 » tumor _ (Expandir a Pesquisa), tumor a (Expandir a Pesquisa)
tumor re » tumor role (Expandir a Pesquisa), tumor rna (Expandir a Pesquisa)
tumor 1 » tumor _ (Expandir a Pesquisa), tumor a (Expandir a Pesquisa)
2581
Por Eimer, Sandrine, Dugay, Frédéric, Airiau, Kelly, Avril, Tony, Quillien, Véronique, Belaud-Rotureau, Marc-Antoine, Belloc, Francis
Publicado em 2012
“... to conventional therapies. Overcoming this resistance is a major challenge to manage this deadly brain tumor...”Publicado em 2012
Obter o texto integral
Obter o texto integral
Obter o texto integral
Artigo
2582
Por Kickingereder, P., Hamisch, C., Suchorska, B., Galldiks, N., Visser-Vandewalle, V., Goldbrunner, R., Kocher, M., Treuer, H., Voges, J., Ruge, M.I.
Publicado em 2014
“... and recurrent tumors (11.1 vs.10.4 months for OS and 6.2 vs. 5.9 months for PFS). For OS, multivariate analysis...”Publicado em 2014
Obter o texto integral
Obter o texto integral
Artigo
2583
Por Nitta, Yusuke, Shimizu, Saki, Shishido‐Hara, Yukiko, Suzuki, Kaori, Shiokawa, Yoshiaki, Nagane, Motoo
Publicado no Cancer Med (2016)
“... tumors exhibited a decrease in expression of the mismatch repair (MMR) proteins, MSH6 and MLH1...”Publicado no Cancer Med (2016)
Obter o texto integral
Obter o texto integral
Obter o texto integral
Artigo
2584
“... and tumor necrosis factor-α) and neuro-hormonal factors (brain natriuretic peptide, endothelin-1...”
Obter o texto integral
Obter o texto integral
Obter o texto integral
Obter o texto integral
Obter o texto integral
Obter o texto integral
Artigo
2585
“... and release pro-inflammatory cytokines and neurotrophins. Brain-derived neurotrophic factor (BDNF) plays a...”
Obter o texto integral
Obter o texto integral
Artigo
2586
Por Gahrmann, R., van den Bent, M., van der Holt, B., Vernhout, R., Taal, W., Taphoorn, M., de Groot, J., Beerepoot, L., Jasperse, B., Smits, M.
Publicado no Neuro Oncol (2016)
“...PURPOSE: Response assessment in brain tumors is currently done with the 2D Response Assessment...”Publicado no Neuro Oncol (2016)
Obter o texto integral
Obter o texto integral
Artigo
2587
Por MA, Qianli, LIU, Deruo, GUO, Yongqing, SHI, Bin, SONG, Zhiyi, TIAN, Yanchu
Publicado no Zhongguo Fei Ai Za Zhi (2010)
“... prognosis. METHODS: 165 out of 173 patients with N2 NSCLC were treated with surgery in our department from...”Publicado no Zhongguo Fei Ai Za Zhi (2010)
Obter o texto integral
Obter o texto integral
Obter o texto integral
Artigo
2588
Por Kommidi, Harikrishna, Tosi, Umberto, Maachani, Uday B., Guo, Hua, Marnell, Christopher S., Law, Benedict, Souweidane, Mark M., Ting, Richard
Publicado no ACS Med Chem Lett (2018)
“... approach to treat cancer, as HDAC overexpression is common in many malignancies. The blood–brain barrier...”Publicado no ACS Med Chem Lett (2018)
Obter o texto integral
Obter o texto integral
Obter o texto integral
Artigo
2589
Por Linda M. Liau, Keyoumars Ashkan, David D. Tran, Jian L. Campian, John E. Trusheim, Charles S. Cobbs, Jason A. Heth, Michael Salacz, Sarah Taylor, Stacy D. D’Andre, Fabio M. Iwamoto, Edward J. Dropcho, Yaron A. Moshel, Kevin A. Walter, Clement P. Pillainayagam, Robert Aiken, Rekha Chaudhary, Samuel A. Goldlust, Daniela A. Bota, Paul Duic, Jai Grewal, Heinrich Elinzano, Steven A. Toms, Kevin O. Lillehei, Tom Mikkelsen, Tobias Walbert, Steven R. Abram, Andrew J. Brenner, Steven Brem, Matthew G. Ewend, Simon Khagi, Jana Portnow, Lyndon J. Kim, William G. Loudon, Reid C. Thompson, David E. Avigan, Karen L. Fink, Francois J. Geoffroy, Scott Lindhorst, Jose Lutzky, Andrew E. Sloan, Gabriele Schackert, Dietmar Krex, Hans-Jorg Meisel, Julian Wu, Raphael P. Davis, Christopher Duma, Arnold B. Etame, David Mathieu, Santosh Kesari, David Piccioni, Manfred Westphal, David S. Baskin, Pamela Z. New, Michel Lacroix, Sven-Axel May, Timothy J. Pluard, Victor Tse, Richard M. Green, John L. Villano, Michael Pearlman, Kevin Petrecca, Michael Schulder, Lynne P. Taylor, Anthony E. Maida, Robert M. Prins, Timothy F. Cloughesy, Paul Mulholland, Marnix L. Bosch
Publicado em 2018-05-01
“...). Results For the intent-to-treat (ITT) population (n = 331), median OS (mOS) was 23.1 months from surgery...”Publicado em 2018-05-01
Obter o texto integral
Artigo
2590
Por Nutchareeporn Nillert, Chantana Boonyarat, Jariya Umka Welbat, Komsun Bunreungthong, Ploenthip Puthongking, Wanassanun Pannangrong
Publicado em 2022-04-01
“... and release of pro-inflammatory cytokines, including interleukin-1β (IL-1β) and tumor necrosis factor-α (TNFα...”Publicado em 2022-04-01
Obter o texto integral
Artigo
2591
Por Choi Im Seup, Choi Dong-Young, Lee Young-Jung, Han Jin-Yi, Jeong Heon-Sang, Han Sang Bae, Oh Ki-Wan, Hong Jin Tae
Publicado em 2011-10-01
“... and microglial BV-2 cells were treated with LPS (1 μg/ml) for 24 h, in the presence (1, 2, 5 μM) or absence...”Publicado em 2011-10-01
Obter o texto integral
Artigo
2592
Por Santosham, Roy, Dev, Bhawna, Priyadarshini, Preeti, Chadga, Harsha, Anupama, C, Santosham, Rajiv, Santosham, Rajan, Vishnu, S
Publicado em 2008
“... inexpensive. RFA has been used to treat tumors located in the liver, lung, bone, kidneys, brain, thyroid...”Publicado em 2008
Obter o texto integral
Artigo
2593
Por Isabel Gugel, Isabel Gugel, Victor-Felix Mautner, Victor-Felix Mautner, Lan Kluwe, Lan Kluwe, Marcos Soares Tatagiba, Marcos Soares Tatagiba, Martin Ulrich Schuhmann, Martin Ulrich Schuhmann, Martin Ulrich Schuhmann
Publicado em 2018-09-01
“...Background and Purpose: Neurofibromatosis Type 2 (NF2) is an autosomal-dominant tumor-prone...”Publicado em 2018-09-01
Obter o texto integral
Artigo
2594
“... and the pathological diagnosis was identical to the previous one. He had no evidence of VHL disease...”
Obter o texto integral
Obter o texto integral
Obter o texto integral
Obter o texto integral
Obter o texto integral
Obter o texto integral
Artigo
2595
Por Castro, Maria G., Candolfi, Marianela, Kroeger, Kurt, King, Gwendalyn D., Curtin, James F., Yagiz, Kader, Mineharu, Yohei, Assi, Hikmat, Wibowo, Mia, Muhammad, AKM Ghulam, Foulad, David, Puntel, Mariana, Lowenstein, Pedro R.
Publicado em 2011
“... therapy will provide a powerful approach to treat and manage brain tumors....”Publicado em 2011
Obter o texto integral
Obter o texto integral
Artigo
2596
Por Lee, Seong-Jong, Hwang, Sun-Chul, Im, Soo Bin, Kim, Bum-Tae
Publicado no Brain Tumor Res Treat (2016)
“...BACKGROUND: Direct surgery to resect tumors in the motor cortex could improve neurological symptoms...”Publicado no Brain Tumor Res Treat (2016)
Obter o texto integral
Obter o texto integral
Obter o texto integral
Artigo
2597
Por Injac, Sarah, Huang, Lei, Zhao, Hong, Qi, Lin, Kogiso, Mari, Man, Chris, Li, Xiao-Nan, Lau, Ching, Wong, Stephen
Publicado no Neuro Oncol (2017)
“...Medulloblastoma (MB) is the most common malignant brain tumor of childhood. While the current...”Publicado no Neuro Oncol (2017)
Obter o texto integral
Obter o texto integral
Artigo
2598
“...BACKGROUND: Glioblastoma is the deadliest and most prevalent brain tumor. Dexamethasone (DXM) is a...”
Obter o texto integral
Obter o texto integral
Obter o texto integral
Obter o texto integral
Obter o texto integral
Obter o texto integral
Artigo
2599
“... and young adults. The World Health Organization 2016 classification of brain tumors defines diffuse midline...”
Obter o texto integral
Obter o texto integral
Obter o texto integral
Obter o texto integral
Artigo
2600
Por Kim, Chae-Young, Park, Soon-Hye, Jeong, Moonsup, Kwon, O-Seo, Doh, Hyounmie, Kang, Su-Hyung, Robbins, Paul D., Kim, Byong-Moon, Seol, Dai-Wu, Kim, Byung-Gee
Publicado em 2011
“...Malignant glioma is the most frequent type in brain tumors. The prognosis of this tumor has...”Publicado em 2011
Obter o texto integral
Obter o texto integral
Obter o texto integral
Artigo